| Application no. and date | 13708603.9 (espacenet) (Federated) (European Patent Register), 20130225 | | Patent/reg. no. and date | DK/EP 2820016, 20170802 | | Publication date | 20150107 | | Priority no. and date | US 201261603598 P, 20120227 | | EP pub. no. and date |
EP 2820016 20150107 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V140942 | | Inventor | WEI, Chenkou, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
ROBERTS, Daniel Richard, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
SCHARTMAN, Richard Raymond, 27 Cliffside Drive
Wallingford, Connecticut 06492, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61P 11/00 (2006.01) , A61P 25/00 (2006.01) , C07D 471/04 (2006.01) | | Title | N-(5S,6S,9R)-5-AMINO-6-(2,3-DIFLUORPHENYL)-6,7,8,9-TETRAHYDRO-5H-
CYCLOHEPTA[B]PYRIDIN-9-YL-4-(2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-1-
YL)PIPERIDIN-1-CARBOXYLAT, HEMISULFATSALT | | Int. application no. | US2013027648 | | Int. publication no. | WO2013130402 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
